Displaying items by tag: neuroscience
Scientists at UAB have homed in on a protein structure in the brain that may be a promising target for new therapies to treat Parkinson’s disease.
Tagged under
Tagged under
No current therapy for multiple sclerosis exists to halt the progression of this autoimmune disease.
Tagged under
A new screening tool developed at UAB has been shown to be an effective aid in determining the severity of cognitive issues.
Tagged under
Selective regulation of neurons can help investigate brain development, and the mechanisms in learning and neuropsychiatric diseases.
Tagged under
Tagged under
Graduates of the UAB Anatomical Sciences program will help meet a growing need for anatomists in health care programs.
Tagged under
An animal model for mild traumatic brain injury shows microscopic neuropathology, as well as neurophysiological and biochemical changes.
Tagged under
Tagged under
Dawson, a junior majoring in neuroscience, also won the Interview and Talent awards and was awarded $2,900 in scholarships.
Tagged under
More than a third of people have the biology of Alzheimer’s disease but not the symptoms. Understanding why could lead to new therapies.
Tagged under
UAB investigators are looking at the intriguing possibility of a connection between the gut microbiome and Parkinson’s disease.
Tagged under
Examination of a larger group of patients extends the clinical manifestations first described 11 years ago.
Tagged under
Tagged under
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
Tagged under
The goal is an early warning system to block incipient seizures for patients where medications have failed.
Tagged under
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
Tagged under
These newborn neurons in the dentate gyrus become less excitable after three weeks, a crucial step for mature functioning.
Tagged under
Early results for a UAB-developed viral immunotherapy to treat brain tumors in children demonstrate safety and tolerability in Phase I studies.
Tagged under